Patheon NV (extinct)

Patheon NV (extinct)

Patheon NV (extinct)

Overview
Date Founded

2013

Headquarters

Evert van de Beekstraat 104,Amsterdam, Noord-Holland 1118 CN

Type of Company

Private

Employees (Worldwide)

4,700

Industries

Pharmaceuticals

Company Description

Patheon NV engages in the provision of pharmaceutical development and manufacturing services. It focuses on drug development, clinical trial logistics, and commercial manufacturing. The company was founded on December 24, 2013 and is headquartered in Amsterdam, the Netherlands.

Contact Data
Trying to get in touch with decision makers at Patheon NV? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Paths to Patheon NV
Potential Connections via
Relationship Science
You
Patheon NV
Recent Transactions
Details Hidden

Thermo Fisher Scientific, Inc. purchases Patheon NV from JLL Partners, Inc.

Details Hidden

Patheon NV purchases Roche Carolina, Inc. from Roche Holding AG resulting in a new company Patheon API, Inc.

Details Hidden

Patheon NV issued USD Ordinary Shares

Transaction Advisors
Investment Advisor

Advised onThermo Fisher Scientific, Inc. purchases Patheon NV from JLL Partners, Inc.

Escrow Agent

Advised onPatheon NV issued USD Ordinary Shares

Underwriter

Advised onPatheon NV issued USD Ordinary Shares

Legal Advisor

Advised onThermo Fisher Scientific, Inc. purchases Patheon NV from JLL Partners, Inc.

Legal Advisor

Advised onThermo Fisher Scientific, Inc. purchases Patheon NV from JLL Partners, Inc.

Legal Advisor

Advised onThermo Fisher Scientific, Inc. purchases Patheon NV from JLL Partners, Inc.

Advisors & Consultants
Legal Advisor

Partner at Davis Polk & Wardwell LLP

Advisor

Vice President at JM Search & Co.

Clients

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Part of Thermo Fisher Scientific, Inc., Banner Life Sciences LLC is a company headquartered in High Point, NC, that engages in pharmaceutical preparation.The company says this about itself: Banner Life Sciences LLC, a privately held clinical-stage pharmaceutical company, combines a proven history of formulation expertise with proprietary technologies to create specialty pharmaceuticals that solve real unmet clinical needs.

Key Stats and Financials As of
Market Capitalization
$5.08B
Total Enterprise Value
Earnings Per Share
Investors
Details Hidden

NB Alternatives Advisers invests in private equity funds managed by leading sponsors and also makes direct private equity investments alongside leading sponsors. It seeks to produce attractive returns on their capital while managing investment risk through portfolio diversification across asset class, vintage year, geography, industry and sponsor, employ multiple tools to actively manage our private equity portfolio. The firm pursues an over-commitment strategy which utilizes a credit facility to provide a ready source of long-term capital to meet future capital calls, provide flexibility to make investments and enhance investment returns. They also use co-investments to manage their investment pace over time.

Details Hidden

JLL Partners focuses on healthcare, financial services, industrial, building products, education, aerospace and defense and business services sectors located in North America.JLL Partners is a control investor and sources its deals from its deep network of industry contacts, applying its proven, value-oriented investment approach to provide limited partners with attractive risk-adjusted returns throughout all investment cycles. They seek to add value and insight by sharing their financial and operational expertise with fundamentally strong companies experiencing regulatory, legal, operational or financial difficulties that prevent them from taking advantage of favorable, long-term, secular growth trends in their industry.The firm closely and actively partners with proven management teams to build market-leading companies. They go beyond financial support, and provide their portfolio companies with the operating experience, in developing new products and executing bolt-on acquisitions.

Details Hidden

Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM’s 23,500 employees deliver annual net sales of around €9 billion. The company is listed on NYSE Euronext.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Patheon NV. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Patheon NV's profile does not indicate a business or promotional relationship of any kind between RelSci and Patheon NV.